We would love to hear your thoughts about our site and services, please take our survey here.
Having been in stocks that have been in similar situation as this one, my advice to anyone invested, is believe what the company has told you so far. Don’t get sucked into the conspiracy theories being mentioned on this board. The company hasn’t mentioned anything about secret buyers, or potential secret buyers in their last RNS. What you do know is that the company is about to be taken private, and that the shares will be delisted. Make your decisions based on your own research, and go over every last detail in that last RNS with a fine tooth comb.
GL.
I fully understand why some feel the company could go private. In the Presentation Q&A, when asked if the company could go private, the CEO replied "no comment", and when asked again, he said he doesn't want to comment on it. That was very very telling. But I agree, the company has huge potential and sales have increased substantially lately. If we can expand to another fifteen or so sites, then we can start dreaming bigger.
Mountainous - I’m glad you didn’t invest too much over here, it’s always better to lose a little than lose the lot. The AIM is probably the most dangerous market in the world right now, mostly caused by the state of the economy. If one wants to survive in this wild market, you have to get in at the right time and more importantly, get out at the right time. Better to stay with the safe stocks that are financially stable and are generating income. If one is going to play around with stocks that are spending more than they are earning, and have a small MCAP, you have to proceed with the utmost caution. You can’t be dithering when it’s time to get out, always remember it drops just as fast as it rises.
Listen, I feel your pain, same thing happened over at CINE. These AIM stocks is no joke, you can get wiped out in an instant. The companies on AIM don't give a fig about shareholders. The amount of debt this company had should have been a warning. Yet you still had some on here saying the business was worth 500M, utter rubbish. Dont ever listen to the rampers, dyor and if you smell a rat or the books looks cooked, get the hell out as fast as you can. Which is why I scarpered with a small loss when I heard there was no guarantee that a takeover will happen. I smelt a rat immediately, and it became clear what game the company was playing. So I sold and glad I did, f... em, they dont give a f... so why should you.
Silverblade - I agree the dilution is bad, but it's gone from 95M - 120M not 150M. Still not too bad, and the latest dilution should be the last. The company now has enough money to keep the lights on and see out the Takeover bid.
I've only invested in RENX because it has the KidneyIntelX platform which is FDA approved and being used and fully funded by Medicare. It's also being used by major United States Insurance companies and multiple state Blue Cross Blue Shield organizations. RENX has huge potential and could be about to be taken over by a big pharmaceutical company. That's the only reason I'm here, If it was because of it finances, I would have stayed well clear of this company, it burns through far too much cash. This Takeover has possibly come at just the right time.
GDR are flat broke and will be seeking funding very soon, as early as the coming weeks or days. I think Mr Cheek will have something up his sleeve regarding funding. I see a big player stepping in to finance the company. The company's product is already being rolled out within the NHS, with the stroke test following closely behind. Genedrive may be low on cash but they certainly have sound fundamentals and great prospects. I see things changing in a big way in the coming weeks and months.
Used to make some good returns from this stock in the Covid days. But the writing was on the wall and I got out before it started heading down. I've learnt from this stock, when investing in a company, make sure to go over their financials with a fine tooth comb, and keep an eye on it regularly. If their accounts doesn't look good or looks very shady, make as much profit as you can and get the hell out of the stock fast. Thats how you've got to treat AIM stocks, even if it means taking a loss, just take as small a loss as you can and get the hell out fast. AIM stocks is no joke especially the way the UK economy is at the moment.
Trickymatters - Too right, we really should be around the 35p mark, just a couple of pennies short. But it's to be expected as the UK are currently in the middle of a recession. Used to be able to get almost two dollars to the pound, now the dollar has almost the same value as the pound.
Having had time to digest the Presentation and the Interim reports, things overall are looking good for the company. We have the AIHL and CYP2C19 being tested and used in clinical settings. According to the latest reports revenue has increased tenfold from 21K previous six months, to 240K. Which means the yearly turnover will be in the region of half a million. That's a big improvement. This will be money that has been generated from the roughly 14 AIHL sites. Slow but steady improvements is good to see. With the CYP2C19 about to be recommended I see nothing but positive news coming in 2024.
Obviously funds will have to be raised, but as long as it's to help fund FDA and help with the AIHL expansion, it will be money well spent. The biggest fear is obviously the share dilution that will be caused having to raise the funds. Hopefully the company will take that into consideration. The telling thing for me though in the Presentaion, was when Mr Cheek became very cagey when asked if the company will be taken private. Mr Cheek blatantly swerved the question and refused to make any comment on it, that was very telling. But overall GDR still has solid fundamentals in place and with their foot already in the NHS door and FDA to come, things can only get better.
So a big week with news finally in of the stroke test. This was supposed to be the mother of all news. This news was supposed to blow the SP to over a pound, I heard some on here saying. Well it didn't , and it's not going to either. But what we did see was a 200% rise and that's great. Hopefully we can find a new support level at this level and move up some more as news starts coming in. We now await the publishing date for the CYP2C19-ID test due in July, and the full and final recommendation for the AIHL which could come anytime now.
These recommendations are actually becoming a bit of a joke. The AIHL which was given final recommendation clearance last year, we now discover was only a conditional recommendation with full and final recommendations to come this year. The stroke test recommendations which will be announced in May, I suppose will again be a conditional recommendation with full and final recommendations to follow. The amount of recommendations these tests have to go through, you have to wonder when and if they will ever get finally recommended. Either way lots to look forward to this year, hopefully improved Sales, and more importantly lots of positive news. As we know sentiment and news is a big factor in driving the stock up.
Holding patiently.
Yes it's looks like it's going that way. It's been a sell off all week, although the buying did pick up towards the end when it dropped below 30. If that continues onto next week, then 30 could become the new support level, although I very much doubt it, the market looks depressing atm. Either way surely we must be close to some takeover news. The 28 day FSP period is officially over, although that doesn't apply due to the dispensation. The longer this goes on, the more we're looking at stalemate.
Johnboi1968 - The rate this is going a lot of us will be getting your last option. A big uplift in the distribution and expansion of the AIHL test, home and abroad, is the best thing we have right now that will get this SP really moving. I hope Mr Cheek delivers.
Last year this time the SP was 87p, in July it hit a high of £1.45. only 3 years ago the SP was £11.75. Then in the space of a year it drops to 10p. Unbelievable. Now I understand that AIM stocks can be very volatile but how do you go from £11.75 to 10p in under three years? Something very very fishy. MMs playing with the SP however they like and the FCA and all these other impotent organisations say and do sweet nothing. The AIM is the biggest pile of poo out of all the markets in the world. Rip off Britain is an under statement, it's an utter disgrace. You stand more chance with the American market and thats a fact.
Trickymatters - I've got a funny feeling the bid will be coming from Mount Sinai School Of Medicine, they already own 16% of the Share capital. Here's another reason:
https://reports.mountsinai.org/article/neph2022-_1_renalytix-goes-into-clinical-use